The Chemours Company (NYSE:CC - Free Report) - Analysts at Zacks Research dropped their Q1 2025 earnings estimates for shares of Chemours in a report issued on Monday, March 3rd. Zacks Research analyst R. Department now expects that the specialty chemicals company will post earnings per share of $0.18 for the quarter, down from their previous forecast of $0.51. The consensus estimate for Chemours' current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours' Q4 2025 earnings at $0.31 EPS, FY2025 earnings at $1.61 EPS, Q1 2026 earnings at $0.45 EPS, Q3 2026 earnings at $0.78 EPS and Q4 2026 earnings at $0.47 EPS.
Chemours (NYSE:CC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion.
Several other analysts have also recently weighed in on CC. Mizuho decreased their price objective on shares of Chemours from $22.00 to $21.00 and set a "neutral" rating on the stock in a research note on Tuesday, January 7th. Truist Financial began coverage on shares of Chemours in a report on Tuesday, January 28th. They set a "buy" rating and a $27.00 price objective on the stock. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $25.00 target price on shares of Chemours in a research note on Thursday, December 12th. Morgan Stanley lowered their price target on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating for the company in a report on Monday, January 13th. Finally, Barclays decreased their price objective on Chemours from $23.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Monday, February 24th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $23.11.
Check Out Our Latest Research Report on Chemours
Chemours Stock Performance
CC stock traded down $0.68 during midday trading on Thursday, hitting $13.44. The stock had a trading volume of 4,702,066 shares, compared to its average volume of 1,546,295. The firm has a market capitalization of $2.01 billion, a price-to-earnings ratio of 23.58 and a beta of 2.00. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The stock has a 50-day simple moving average of $17.44 and a 200 day simple moving average of $18.63. Chemours has a 52 week low of $13.31 and a 52 week high of $29.21.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Chemours in the 4th quarter valued at $30,702,000. Appian Way Asset Management LP bought a new stake in Chemours during the 3rd quarter worth about $34,151,000. Vision One Management Partners LP bought a new stake in Chemours during the third quarter worth $28,252,000. Bank of Montreal Can increased its position in Chemours by 1,496.4% during the fourth quarter. Bank of Montreal Can now owns 953,240 shares of the specialty chemicals company's stock worth $16,110,000 after buying an additional 893,530 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in shares of Chemours by 23.8% in the fourth quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company's stock valued at $73,907,000 after purchasing an additional 839,849 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company's stock.
Chemours Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.44%. Chemours's dividend payout ratio (DPR) is presently 175.44%.
About Chemours
(
Get Free Report)
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Featured Articles
Before you consider Chemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemours wasn't on the list.
While Chemours currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
